Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelly Ziade

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|November 22, 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD studyR Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Modern Rheumatology|September 28, 2023
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD datasetAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology (Oxford, England)|May 25, 2023
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey studyNelly Ziade, Marc Aoude, Ihsane Hmamouchi, et al.
Rheumatology (Oxford, England)|August 3, 2022
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-surveyAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology International|June 14, 2023
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-surveySilvia Grignaschi, Minchul Kim, Giovanni Zanframundo, et al.
RMD Open|January 19, 2021
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA studyClementina López-Medina, Anna Molto, Joachim Sieper, et al.
Rheumatology International|March 31, 2023
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) surveyR Naveen, Darpan R Thakare, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|May 9, 2024
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challengesMrudula Joshi, Naitica Darooka, Sreoshy Saha, et al.
Rheumatology International|April 12, 2024
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD StudiesEsha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|November 22, 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD studyR Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Modern Rheumatology|September 28, 2023
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD datasetAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology (Oxford, England)|May 25, 2023
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey studyNelly Ziade, Marc Aoude, Ihsane Hmamouchi, et al.
Rheumatology (Oxford, England)|August 3, 2022
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-surveyAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology International|June 14, 2023
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-surveySilvia Grignaschi, Minchul Kim, Giovanni Zanframundo, et al.
RMD Open|January 19, 2021
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA studyClementina López-Medina, Anna Molto, Joachim Sieper, et al.
Rheumatology International|March 31, 2023
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) surveyR Naveen, Darpan R Thakare, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|May 9, 2024
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challengesMrudula Joshi, Naitica Darooka, Sreoshy Saha, et al.
Rheumatology International|April 12, 2024
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD StudiesEsha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Muscle & Nerve|July 23, 2022
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesAlbert Gil-Vila, Naveen Ravichandran, Albert Selva-O'Callaghan, et al.
Pageof 8